TECENTRIQ J Code: J9022

Drug & Product Overview

HCPCS Descriptor Injection, atezolizumab, 10 mg

HCPCS Added Date January 1, 2018

Manufacturer Genentech

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About TECENTRIQ

Tecentriq is a medication aligned to the HCPCS J Code: J9022 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Genentech.

According to CMS Drug Use Information: This medication is used to treat various cancers (such as bladder/liver/lung/skin cancer, alveolar soft part sarcoma - ASPS). It works by helping your immune system fight the cancer. Atezolizumab belongs to a class of drugs known as monoclonal antibodies.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
50242-0917-01	Tecentriq	Genentech, Inc.	120	1200 MG / 20 ML
50242-0918-01	Tecentriq	Genentech, Inc.	84	840 MG / 14 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

TECENTRIQ Pricing & Reimbursement

J9022 Private Payer Reimbursement

$96.56 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

TECENTRIQ Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 11.65%

Avg. Days to File 9.1days

Avg. Days to Pay 24.9days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9022 claims analytics on FocalPoint →

TECENTRIQ CPT Administration Codes

CPT Code	Description
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Tecentriq (J9022) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

TECENTRIQ Medically Unlikely Edits (MUE)

The most billing units of J9022 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 10 mg.

Practitioner Office & Hospital Outpatient

168 units / day

= 1,680 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

TECENTRIQ Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Alveolar Soft Part Sarcoma Extensive-Stage Small Cell Lung Cancer Hepatocellular Carcinoma Melanoma Metastatic Non-Small Cell Lung Cancer Metastatic Non-Squamous Non-Small Cell Lung Cancer Muscle Invasive Bladder Cancer Non-Small Cell Lung Cancer

Drug Class

Antibodies [CS]AntibodiesMonoclonal [CS]MonoclonalHumanized [CS]Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Frequently Asked Questions

Is there an available Tecentriq billing and coding guide?

Billing and coding information for TECENTRIQ can be found through Genentech. Visit Here →

Are there any available Tecentriq patient assistance programs?

TECENTRIQ patient assistance information can be found through Genentech. Visit Here →

Where can I find Tecentriq prescribing information?

TECENTRIQ prescribing information can be found at the link below: Visit Here →

Where can I find Tecentriq side effect information?

Information regarding TECENTRIQ's side effects can be found at MedlinePlus Visit Here →

Does billing TECENTRIQ require JZ/JW wastage modifiers?

CMS has identified TECENTRIQ(J9022) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.